ClinicalTrials.Veeva

Find clinical trials for Chronic Lymphocytic Leukemia in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Chronic Lymphocytic Leukemia
Leukemia
Lymphoid Leukemia
Lymphoma
B-Cell Lymphoma
Mantle-Cell Lymphoma
Non-Hodgkin Lymphoma

Chronic Lymphocytic Leukemia trials near San Antonio, TX, USA:

Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (BRUIN CLL-321)

This is a study for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL)...

Active, not recruiting
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Idelalisib
Drug: Bendamustine

Phase 3

Loxo Oncology
Loxo Oncology

San Antonio, Texas, United States and 231 other locations

Follicular Lymphoma is a slow-growing type of non-Hodgkin lymphoma. Chronic lymphocytic leukemia (CLL) is the most common ...

Enrolling
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Drug: ABBV-319

Phase 1

AbbVie
AbbVie

San Antonio, Texas, United States and 12 other locations

The purpose of this study is to evaluate the efficacy and safety of acalabrutinib in combination with venetoclax and acalabrutinib in combination wit...

Active, not recruiting
Chronic Lymphocytic Leukemia
Drug: Venetoclax
Drug: Obinutuzumab

Phase 3

Acerta Pharma
Acerta Pharma

Fort Sam Houston, Texas, United States and 170 other locations

the efficacy of acalabrutinib compared with rituximab in combination with idelalisib or bendamustine in previously treated subjects with chronic...

Active, not recruiting
Chronic Lymphocytic Leukemia
Drug: Idelalisib
Drug: Acalabrutinib (ACP-196)

Phase 3

Acerta Pharma
Acerta Pharma

Fort Sam Houston, Texas, United States and 156 other locations

The purpose of this study is to characterize safety and to determine the putative recommended Phase 2 dose(s) (RP2D[s]) and optimal dosing schedule(s...

Enrolling
Leukemia, Lymphocytic, Chronic, B-Cell
Lymphoma, Non-Hodgkin
Drug: JNJ-80948543

Phase 1

Janssen
Janssen

San Antonio, Texas, United States and 22 other locations

with obinutuzumab (Arm B) for the treatment of previously untreated chronic lymphocytic leukemia (CLL). Secondary objectiv...

Active, not recruiting
Chronic Lymphocytic Leukemia
Drug: Acalabrutinib
Drug: Chlorambucil

Phase 3

Acerta Pharma
Acerta Pharma

San Antonio, Texas, United States and 154 other locations

This study is a first-in-human, Phase 1a/1b, multicenter, open-label study to determine the safety, tolerability, and pharmacokinetics of aplitabart...

Enrolling
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Bevacizumab (and approved biosimilars)
Drug: FOLFIRI

Phase 1

IGM Biosciences

San Antonio, Texas, United States and 57 other locations

This study is being done to evaluate the safety, tolerability and effectiveness of Oral CG-806 for the treatment of patients with chronic ly ...

Active, not recruiting
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: CG-806

Phase 1

Aptose Biosciences

San Antonio, Texas, United States and 29 other locations

This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX112™ in subjects with relapsed or refractory B-cell mali...

Enrolling
Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Marginal Zone Lymphoma
Biological: CTX112

Phase 1, Phase 2

CRISPR Therapeutics

San Antonio, Texas, United States and 1 other location

This study is evaluating the safety, pharmacodynamics (PD), and efficacy of acalabrutinib and pembrolizumab in hematologic malignancies.

Active, not recruiting
Small Lymphocytic Lymphoma (SLL)
Hairy Cell Leukemia
Drug: Acalabrutinib
Drug: Pembrolizumab

Phase 1, Phase 2

Acerta Pharma
Acerta Pharma

San Antonio, Texas, United States and 18 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems